Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors

Overview of attention for article published in OncoTargets and therapy, January 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 85 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,039 followers.

Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors B Zulfiqar et al. 2017 https://t.co/R5lVfeMnnW

Reply Repost Favourite

Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors #immunotherapy https://t.co/5bEWmhXdCf

Reply Repost Favourite